This inventor holds 23 USPTO granted patents, primarily in Radiolabeled Peptides. Top assignees: Diatide, Inc., Diatech, Inc., Cis Bio International. Active years: 1995-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Summit, NJ (US) (1999 - 2001)
- Manchester, NH (US) (1995 - 2007)
Company Filing History:
19 out of 80 
3 out of 12 
1 out of 51 
Years Active: 1995-2007
Areas of Expertise:
Title: Innovations by William McBride in Therapeutic Agents
Introduction
William McBride, based in Manchester, NH, has made significant contributions to the field of therapeutics, holding an impressive portfolio of 23 patents. His work primarily focuses on developing innovative medical compounds aimed at addressing various health disorders.
Latest Patents
Among McBride's latest patents are the development of monoamine, diamide, thiol-containing metal chelating agents, specifically therapeutic thiazole derivatives. These compounds are geared towards therapies to treat or prevent disorders characterized by the overexpression of transforming growth factor (TGF-β). Additionally, he has patented somatostatin derivatives and their radiolabelled products, which encompass therapeutic and radiodiagnostic reagents and peptides. This innovation particularly highlights linear peptide derivatives of somatostatin that are radiolabelled with isotopes such as technetium-99m and rhenium-186 and rhenium-188 for radiotherapeutic applications and scintigraphic imaging.
Career Highlights
Throughout his career, McBride has worked with notable companies, including Diatide, Inc. and Diatech, Inc. His expertise in creating pharmaceutical compositions has significantly contributed to advancements in therapies, particularly concerning complex disorders that require innovative approaches.
Collaborations
William McBride has collaborated with accomplished professionals such as Richard T. Dean and John Lister-James. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of numerous therapeutic agents.
Conclusion
William McBride exemplifies dedication and innovation in the field of pharmaceuticals. With a wealth of patents to his name, his contributions are paving the way for new therapeutic solutions, greatly impacting the treatment landscape for various diseases. His work continues to inspire future developments in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile